Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Targeted Therapy

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Targeted Therapy

Chen D, Le SB, Ghiaseddin AP, Manektalia H, Li M, O'Dell A, Rahman M, Tran DD.
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study.
Med. 2025 Jun 3:100708. doi: 10.1016/j.medj.2025.100708. PMID: 40466642. Interventional study. ˍ